Description:

Treanda (news articles) is a drug that is used to treat chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin's lymphoma (NHL) .  It is also being studied in the treatment of other types of cancer. Treanda is a type of …

The FDA last Friday granted approval to Cephalon, Inc. to market the drug Treanda (bendamustine) for the treatment of indolent non-Hodgkin’s lymphoma (NHL).

Just seven months ago, the FDA also approved Treanda for the treatment of chronic lymphocytic leukemia (CLL), making Treanda the only new drug this year to gain FDA approval for two cancer indications.

Treanda is not officially approved in the United States for the treatment of multiple myeloma. It is, however, approved in Germany for multiple myeloma as well as indolent NHL and CLL. …